Search
for
Sort by
Research 241–270 of 397
- Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
- Female Pattern Hair Loss
- Transgender Competent Provider
- Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter’s Methylation in AFAB People
- Approach to androgen excess in women: Clinical and biochemical insights
- The therapeutic use of androgens in women
- LBMON231 Virilization Secondary To Androgen Producing Ovarian Serous Cystadenoma
- Sertoliform endometrioid carcinoma of the right ovary
- (101) Ovarian Hyperthecosis as a Cause of Hypersexualization in a Post-menopausal Female
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Testosterone Therapy in Premenopausal Women
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- A review of hyperandrogenism state in polycystic ovarian syndrome
- Alopecia and Hirsuties
- DIAGNOSTIC AND THERAPEUTIC UTILITY OF GONADOTROPHIN-RELEASING HORMONE AGONIST IN POSTMENOPAUSAL HYPERANDROGENISM OF OVARIAN ORIGIN
- 6 Current concepts of polycystic ovary syndrome
- Androgenic alopecia and hirsutism in a 73-year-old woman: careful re-evaluation of 'normal' imaging findings may lead to a rare diagnosis
- Androgen Action in the Ovary
- Endocrine intervention for transsexuals
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Polycystic Ovary Syndrome Is a Challenging Problem in Women
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Alopecia and hirsutism*
- Adult polycystic ovary syndrome begins in childhood
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- What is the Rationale for Androgen Therapy for Women?